Dr. Robbie M Parks' lab focuses on understanding how air pollution, particularly fine particulate matter (PM2.5), impacts the development of Lewy body dementia, a serious neurodegenerative disease. They combine large-scale data analysis with animal studies to identify which specific components of air pollution contribute to the disease's pathology. The lab's ultimate goal is to inform public health policies and therapeutic strategies to mitigate the effects of these environmental factors on aging populations.

Dr. Zhonghua Liu's lab focuses on developing advanced statistical methods to analyze complex genetic and multi-omics data, particularly in relation to Alzheimer's disease. The lab aims to identify biomarkers that can help diagnose the disease early and inform personalized treatment strategies. By leveraging innovative computational algorithms, the team works on understanding the biological processes behind neurodegeneration to improve health outcomes, especially in diverse populations.

Dr. Linda Valeri's lab at Columbia University focuses on using advanced statistical techniques to understand the causes of Alzheimer's Disease and related disorders (ADRD). The research aims to develop new methods for analyzing how various environmental factors and health conditions affect the risk of ADRD over time. By utilizing large cohort studies and sophisticated Bayesian machine learning approaches, the lab seeks to provide insights that can inform prevention strategies and health policies.

Dr. Yifei Sun's lab focuses on developing advanced statistical methods to enhance the analysis of diverse longitudinal cohort studies, particularly in understanding COVID-19 risk factors. By addressing challenges like systematically missing data and study heterogeneity, the lab creates improved tools for clinical and epidemiological research. Their innovative approaches aim to provide reliable resources for researchers integrating data from multiple studies.

Dr. Iuliana Ionita's lab focuses on understanding the genetic factors that contribute to neuropsychiatric disorders, like autism and schizophrenia. By using comprehensive genetic and phenotypic data, the research aims to develop better methods for analyzing the genetic architecture of these complex traits, particularly in diverse populations. This work seeks to improve our understanding of the biological mechanisms influencing mental health conditions, potentially leading to better prevention and treatment strategies.

Ying Wei's lab focuses on understanding Alzheimer's Disease (AD) and related dementias by analyzing genetic data and electronic health records. By using advanced statistical methods and machine learning, the lab aims to identify genetic factors that influence the progression of these diseases over time, particularly as individuals age. This research is crucial for developing better prevention strategies and new treatments for dementia.